More recent work from Haggie et al. (49) and Guidone et al. (16) found that exposure to pharmacological inhibitors of SLC26A4 increased ASL height, or decreased mucus viscosity, respectively, in primary cultures of airway cells (non-CF and CF). The gene discussed is SLC26A4; the disease is cystic fibrosis.